The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immune Globulins-Global Market Insights and Sales Trends 2024
Synopsis
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Immune Globulins market size is expected to reach US$ 25330 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Globulins in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Immune Globulins market. IVIg Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IVIg Powder segment is estimated at % CAGR for the next seven-year period.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Globulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Globulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Globulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Globulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Globulins covered in this report include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc.
The global Immune Globulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Global Immune Globulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Globulins market, Segment by Type:
IVIg Liquid
IVIg Powder
Global Immune Globulins market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immune Globulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Immune Globulins market size is expected to reach US$ 25330 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Globulins in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Immune Globulins market. IVIg Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IVIg Powder segment is estimated at % CAGR for the next seven-year period.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Globulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Globulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Globulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Globulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Globulins covered in this report include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc.
The global Immune Globulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Global Immune Globulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Globulins market, Segment by Type:
IVIg Liquid
IVIg Powder
Global Immune Globulins market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immune Globulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immune Globulins Market Overview
1.1 Immune Globulins Product Overview
1.2 Immune Globulins Market Segment by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Global Immune Globulins Market Size by Type
1.3.1 Global Immune Globulins Market Size Overview by Type (2018-2029)
1.3.2 Global Immune Globulins Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immune Globulins Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immune Globulins Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immune Globulins Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immune Globulins Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immune Globulins Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immune Globulins Sales Breakdown by Type (2018-2023)
2 Global Immune Globulins Market Competition by Company
2.1 Global Top Players by Immune Globulins Sales (2018-2023)
2.2 Global Top Players by Immune Globulins Revenue (2018-2023)
2.3 Global Top Players by Immune Globulins Price (2018-2023)
2.4 Global Top Manufacturers Immune Globulins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Globulins Market Competitive Situation and Trends
2.5.1 Immune Globulins Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Globulins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Globulins as of 2022)
2.7 Date of Key Manufacturers Enter into Immune Globulins Market
2.8 Key Manufacturers Immune Globulins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immune Globulins Status and Outlook by Region
3.1 Global Immune Globulins Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immune Globulins Historic Market Size by Region
3.2.1 Global Immune Globulins Sales in Volume by Region (2018-2023)
3.2.2 Global Immune Globulins Sales in Value by Region (2018-2023)
3.2.3 Global Immune Globulins Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immune Globulins Forecasted Market Size by Region
3.3.1 Global Immune Globulins Sales in Volume by Region (2024-2029)
3.3.2 Global Immune Globulins Sales in Value by Region (2024-2029)
3.3.3 Global Immune Globulins Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immune Globulins by Application
4.1 Immune Globulins Market Segment by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Immune Globulins Market Size by Application
4.2.1 Global Immune Globulins Market Size Overview by Application (2018-2029)
4.2.2 Global Immune Globulins Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immune Globulins Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immune Globulins Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immune Globulins Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immune Globulins Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immune Globulins Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immune Globulins Sales Breakdown by Application (2018-2023)
5 North America Immune Globulins by Country
5.1 North America Immune Globulins Historic Market Size by Country
5.1.1 North America Immune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immune Globulins Sales in Volume by Country (2018-2023)
5.1.3 North America Immune Globulins Sales in Value by Country (2018-2023)
5.2 North America Immune Globulins Forecasted Market Size by Country
5.2.1 North America Immune Globulins Sales in Volume by Country (2024-2029)
5.2.2 North America Immune Globulins Sales in Value by Country (2024-2029)
6 Europe Immune Globulins by Country
6.1 Europe Immune Globulins Historic Market Size by Country
6.1.1 Europe Immune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immune Globulins Sales in Volume by Country (2018-2023)
6.1.3 Europe Immune Globulins Sales in Value by Country (2018-2023)
6.2 Europe Immune Globulins Forecasted Market Size by Country
6.2.1 Europe Immune Globulins Sales in Volume by Country (2024-2029)
6.2.2 Europe Immune Globulins Sales in Value by Country (2024-2029)
7 Asia-Pacific Immune Globulins by Region
7.1 Asia-Pacific Immune Globulins Historic Market Size by Region
7.1.1 Asia-Pacific Immune Globulins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immune Globulins Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immune Globulins Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immune Globulins Forecasted Market Size by Region
7.2.1 Asia-Pacific Immune Globulins Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immune Globulins Sales in Value by Region (2024-2029)
8 Latin America Immune Globulins by Country
8.1 Latin America Immune Globulins Historic Market Size by Country
8.1.1 Latin America Immune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immune Globulins Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immune Globulins Sales in Value by Country (2018-2023)
8.2 Latin America Immune Globulins Forecasted Market Size by Country
8.2.1 Latin America Immune Globulins Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immune Globulins Sales in Value by Country (2024-2029)
9 Middle East and Africa Immune Globulins by Country
9.1 Middle East and Africa Immune Globulins Historic Market Size by Country
9.1.1 Middle East and Africa Immune Globulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immune Globulins Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immune Globulins Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immune Globulins Forecasted Market Size by Country
9.2.1 Middle East and Africa Immune Globulins Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immune Globulins Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Immune Globulins Products Offered
10.1.5 Takeda Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Immune Globulins Products Offered
10.2.5 Grifols Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Immune Globulins Products Offered
10.3.5 CSL Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Immune Globulins Products Offered
10.4.5 Octapharma Recent Development
10.5 Biotest
10.5.1 Biotest Company Information
10.5.2 Biotest Introduction and Business Overview
10.5.3 Biotest Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biotest Immune Globulins Products Offered
10.5.5 Biotest Recent Development
10.6 Kedrion
10.6.1 Kedrion Company Information
10.6.2 Kedrion Introduction and Business Overview
10.6.3 Kedrion Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kedrion Immune Globulins Products Offered
10.6.5 Kedrion Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Company Information
10.7.2 Hualan Bio Introduction and Business Overview
10.7.3 Hualan Bio Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hualan Bio Immune Globulins Products Offered
10.7.5 Hualan Bio Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Introduction and Business Overview
10.8.3 CNBG Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CNBG Immune Globulins Products Offered
10.8.5 CNBG Recent Development
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Company Information
10.9.2 Shanghai RAAS Introduction and Business Overview
10.9.3 Shanghai RAAS Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shanghai RAAS Immune Globulins Products Offered
10.9.5 Shanghai RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CBPO Immune Globulins Products Offered
10.10.5 CBPO Recent Development
10.11 LFB Group
10.11.1 LFB Group Company Information
10.11.2 LFB Group Introduction and Business Overview
10.11.3 LFB Group Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.11.4 LFB Group Immune Globulins Products Offered
10.11.5 LFB Group Recent Development
10.12 BPL
10.12.1 BPL Company Information
10.12.2 BPL Introduction and Business Overview
10.12.3 BPL Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BPL Immune Globulins Products Offered
10.12.5 BPL Recent Development
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Company Information
10.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
10.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sichuan Yuanda Shuyang Immune Globulins Products Offered
10.13.5 Sichuan Yuanda Shuyang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Globulins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Globulins Industrial Chain Analysis
11.4 Immune Globulins Market Dynamics
11.4.1 Immune Globulins Industry Trends
11.4.2 Immune Globulins Market Drivers
11.4.3 Immune Globulins Market Challenges
11.4.4 Immune Globulins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immune Globulins Distributors
12.3 Immune Globulins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
